CompanyTrack
A

AZENCO4 LIMITED

Active Cambridge

Other business support service activities n.e.c.

0 employees
Other business support service activities n.e.c.
A

AZENCO4 LIMITED

Other business support service activities n.e.c.

Founded 22 Jan 2016 Active Cambridge, United Kingdom 0 employees
Other business support service activities n.e.c.
Accounts Submitted 2 Jun 2025
Confirmation Statement Submitted 23 Jan 2025
Net assets £3169.88M £2184.95M 2024 year on year
Total assets £5373.93M £4389.01M 2024 year on year
Total Liabilities £2204.05M
Charges None No charges registered

AI Analysis

AI Analysis

Analyze director networks, ownership patterns, and company connections

CompanyTrack AI can make mistakes. Check important info.

Contact & Details

Registered Address

1 Francis Crick Avenue Cambridge Biomedical Campus Cambridge CB2 0AA United Kingdom

Credit Report

Discover AZENCO4 LIMITED's Credit Score, limit, and payment likelihood.

Mutual Companies

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2016–2024)

Cash in Bank

N/A

Net Assets

£3169.88M

Increased by £2184.95M (+222%)

Total Liabilities

£2204.05M

Turnover

N/A

Employees

N/A

Debt Ratio

41%

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

2 Allotments 200 Shares £2904.89m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
12 Jul 2024100$854.14m$8.54m
4 Jun 2024100$2050.74m$20.51m

Officers

Officers

4 active 4 resigned
Status
Camilla Jane JohnstoneSecretaryUnknownUnknown6 Sept 2019Active
Hannah Victoria TattersallDirectorBritishEngland381 May 2025Active
Iain Alistair CollinsDirectorBritishUnited Kingdom5531 May 2017Active
Matthew Shaun BowdenDirectorBritishEngland4827 Feb 2019Active

Shareholders

Shareholders (1)

Astrazeneca Treasury Limited
100.0%
2,500,000,20123 Jan 2025

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Astrazeneca Treasury Limited

United Kingdom

Active
Notified 6 Apr 2016
Nature of Control
  • Ownership Of Shares 75 To 100 Percent
  • Voting Rights 75 To 100 Percent
  • Right To Appoint And Remove Directors

Group Structure

Group Structure

ASTRAZENECA TREASURY LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors
ASTRAZENECA UK LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors
ASTRAZENECA INTERMEDIATE HOLDINGS LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors
ASTRAZENECA PLC united kingdom
AZENCO4 LIMITED Current Company

Charges

Charges

No charges registered

Documents

Company Filings

DateCategoryDescriptionDocument
25 Jun 2025ResolutionResolutionsView(1 page)
25 Jun 2025CapitalCapital Statement Capital Company With Date Currency FigureView(3 pages)
25 Jun 2025InsolvencySolvency Statement dated 24/06/25View(1 page)
25 Jun 2025CapitalStatement by DirectorsView(1 page)
2 Jun 2025AccountsAnnual accounts made up to 2024-12-31View(18 pages)
25 Jun 2025 Resolution

Resolutions

25 Jun 2025 Capital

Capital Statement Capital Company With Date Currency Figure

25 Jun 2025 Insolvency

Solvency Statement dated 24/06/25

25 Jun 2025 Capital

Statement by Directors

2 Jun 2025 Accounts

Annual accounts made up to 2024-12-31

Recent Activity

Latest Activity

Resolutions

7 months ago on 25 Jun 2025

Capital Statement Capital Company With Date Currency Figure

7 months ago on 25 Jun 2025

Solvency Statement dated 24/06/25

7 months ago on 25 Jun 2025

Statement by Directors

7 months ago on 25 Jun 2025

Annual accounts made up to 2024-12-31

8 months ago on 2 Jun 2025